Article Text

Download PDFPDF

4CPS-152 Chemotherapy pharmaceutical consultation: pharmaceutical interventions after 18 months of implementation
  1. E Gerardin1,
  2. E Protesti1,
  3. R Cohen-Valensi2,
  4. S Martinez1,
  5. T Berod1
  1. 1Centre Hospitalier de Martigues, Pharmacy, Martigues, France
  2. 2Centre Hospitalier de Martigues, Haematology, Martigues, France


Background In January 2017, our pharmacy department implemented an oral chemotherapy pharmaceutical consultation in which the order was checked, a medication review was done and drugs information provided (toxicity, taking drug, drug-drug interaction) and completed by an information sheet for patients. In order to promote therapy monitoring, side-effects’ management and treatment adherence, we contacted health professionals: nurse, physician, oncologist and community pharmacist.

Purpose Eighteen months after the implementation of the pharmaceutical consultation the purpose was to assess pharmaceutical interventions on patients, oncologists, physicians and community pharmacists.

Material and methods Revision of our consultation sheets from January 2017 to June 2018.

Sixty-four pharmaceutical consultations occurred for 56 patients (33 males; 28 females; mean 69 years (33–93) with an average time of 33.4 min.

Results Seventy-nine medication-related problems were reported: 31 side effects, 15 drug-drug interactions, 10 absences of adapted comedication and eight inobservances.

One-hundred and two pharmaceutical interventions had been achieved: 51 on patients, 28 on oncologists, 18 on community pharmacists, four on nurses and one on a physician. During pharmaceutical consultation 51 patient information sheets on oral chemotherapy were given to patients, who mostly had medium or bad theoretical (n=31) and technical (n=22) knowledge about their oral chemotherapy, which could reduce its efficacy. Twenty-eight feedbacks were transmitted to oncologists by phone, face-to-face or secure mail. Eighty-two per cent of pharmaceutical interventions were accepted by oncologists. Eighteen community pharmacists had been contacted by phone. A consultation report condensed and patient information sheets were sent to them by fax (n=15) or secure e-mail (n=3). Four nurses had received information by phone on modalities of storage, administration, waste and side-effects’ management. One physician was contacted for a drug-drug interaction.

Our first results showed the quantitative and qualitative importance of pharmacist interventions with patients and other health professionals. However, to improve the quality of our consultations we must develop a systemic and easy feedback to these professionals. A follow-up for the patients during the treatment will be useful.

Conclusion Completed by patient information sheets and feedback, the pharmaceutical consultations appear essential to facilitate care by other health professionals and to give patients significant information concerning their health.

References and/or acknowledgements No conflict of interest.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.